Last reviewed · How we verify
RSV A Memphis 37
At a glance
| Generic name | RSV A Memphis 37 |
|---|---|
| Also known as | M37 |
| Sponsor | Imperial College London |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- The Impact of Age on Adaptive Immunity in Adults Infected With Respiratory Syncytial Virus (NA)
- Cell Mediated Immunity Against RSV and Influenza in a Human Experimental Challenge (NA)
- The Development of a Human Model of Respiratory Syncytial Virus Infection (NA)
- Novel Mucosal Correlates Of RSV Protection In Older Adults (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |